Filing Details

Accession Number:
0001209191-21-046030
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-07-08 18:17:32
Reporting Period:
2021-07-06
Accepted Time:
2021-07-08 18:17:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576885 Acumen Pharmaceuticals Inc. ABOS Biological Products, (No Disgnostic Substances) (2836) 364108129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1709418 Iii A John Stalfort C/o Acumen Pharmaceuticals, Inc.
427 Park Street
Charlottesville VA 22902
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-07-06 130,180 $0.00 137,324 No 4 C Direct
Common Stock Acquisiton 2021-07-06 35,000 $16.00 172,324 No 4 P Direct
Common Stock Acquisiton 2021-07-06 131,595 $0.00 131,595 No 4 C Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
No 4 C Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A-1 Preferred Disposition 2021-07-06 130,180 $0.00 130,180 $0.00
Common Stock Series B Preferred Disposition 2021-07-06 131,595 $0.00 131,595 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Indirect
Footnotes
  1. On July 6, 2021, each share of Series A-1 Convertible Preferred Stock and each share of Series B Convertible Preferred Stock converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
  2. The securities are held by Gineane Holly Stalfort, as Trustee of the John A. Stalfort III 2018 Irrevocable Trust under agreement dated as ofOctober 25, 2018.